Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-047284
Filing Date
2024-11-12
Accepted
2024-11-12 17:05:46
Documents
89
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dna-20240930.htm   iXBRL 10-Q 1625688
2 EX-31.1 dna-20240930xex311.htm EX-31.1 11791
3 EX-31.2 dna-20240930xex312.htm EX-31.2 11808
4 EX-32.1 dna-20240930xex321.htm EX-32.1 5902
5 EX-32.2 dna-20240930xex322.htm EX-32.2 6014
  Complete submission text file 0001628280-24-047284.txt   9138061

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20240930.xsd EX-101.SCH 59914
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dna-20240930_cal.xml EX-101.CAL 85207
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20240930_def.xml EX-101.DEF 409634
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20240930_lab.xml EX-101.LAB 710898
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20240930_pre.xml EX-101.PRE 591906
92 EXTRACTED XBRL INSTANCE DOCUMENT dna-20240930_htm.xml XML 1389019
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40097 | Film No.: 241449720
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)